References
Magiakou MA, Smyrnaki P, Chrousos GP (2006) Hypertension in Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab 20:467–482
Cicala MV, Mantero F (2010) Hypertension in Cushing’s syndrome: from pathogenesis to treatment. Neuroendocrinology. 92(Suppl 1):44–49
Kirilov G, Tomova A, Dakovska L, Kumanov P, Shinkov A, Alexandrov AS (2003) Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing’s syndrome. Eur J Endocrinol 149:549–553
Mangos GJ, Whitworth JA, Williamson PM, Kelly JJ (2003) Glucocorticoids and the kidney. Nephrology (Carlton) 8:267–273
Baid S, Nieman LK (2004) Glucocorticoid excess and hypertension. Curr Hypertens Rep 6:493–499
McFarlane SI, Banerji M, Sowers JR (2001) Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 86:713–718
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709–717
Weiner ID, Wingo CS (1997) Hypokalemia--consequences, causes, and correction. J Am Soc Nephrol 8:1179–1188
Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol 40:479–484
Clayton RN, Raskauskiene D, Reulen RC, Jones PW (2011) Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 96:632–642
Arnardóttir S, Sigurjonsdóttir HA (2011) The incidence and prevalence of Cushing’s disease may be higher than previously thought: results from a retrospective study in Iceland 1955 through 2009. Clin Endocrinol 74:792–793
Ragnarsson O, Olsson DS, Chantzichristos D, Papakokkinou E, Dahlqvist P, Segerstedt E, Olsson T, Petersson M, Berinder K, Bensing S, Hoybye C, Eden Engstrom B, Burman P, Bonelli L,Follin C, Petranek D, Erfurth EM, Wahlberg J, Ekman B, Akerman AK, Schwarcz E, Bryngelsson IL, Johannsson G (2019) The incidence of Cushing’s disease: a nationwide Swedish study. Pituitary. 22:179–186
Bolland MJ, Holdaway IM, Berkeley JE, Lim S, Dransfield WJ, Conaglen JV, Croxson MS, Gamble GD, Hunt PJ, Toomath RJ (2011) Mortality and morbidity in Cushing’s syndrome in New Zealand. Clin Endocrinol 75:436–442
Lindholm J, Juul S, Jørgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 86:117–123
Wengander S, Trimpou P, Papakokkinou E, Ragnarsson O (2019) The incidence of endogenous Cushing’s syndrome in the modern era. Clin Endocrinol 91:263–270
Sharma ST, Nieman LK, Feelders RA (2015) Cushing’s syndrome: epidemiology and developments in disease management. Clin Epidemiol 7:281–293
Lodish MB, Keil MF, Stratakis CA (2018) Cushing’s syndrome in pediatrics: an update. Endocrinol Metab Clin N Am 47:451–462
Stratakis CA (2012) Cushing syndrome in pediatrics. Endocrinol Metab Clin N Am 41:793–803
Ismail H, Broniszczak D, Markiewicz-Kijewska M, Ciopiński M, Teisseyre J, Kluge P, Dembowska-Baginska B, Kosciesza A, Socha P, Kalicinski P (2016) Metastases of pancreatic neuroendocrine tumor to the liver as extremely rare indication for liver transplantation in children. Case report and review of the literature. Clin Res Hepatol Gastroenterol 40:e33–e37
Rosado B, Gores GJ (2004) Liver transplantation for neuroendocrine tumors: progress and uncertainty. Liver Transpl 10:712–713
Navalkele P, O’Dorisio MS, O’Dorisio TM, Zamba GKD, Lynch CF (2011) Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006. Pediatr Blood Cancer 56:50–57
Cives M, Strosberg JR (2018) Gastroenteropancreatic neuroendocrine tumors. Cancer J Clin 68:471–487
Franchi G, Manzoni MF (2014) Cytological Ki-67 in pancreatic endocrine tumors: a new “must”? Gland Surg 3:219–221
Zimmer T, Ziegler K, Liehr RM, Stölzel U, Riecken EO, Wiedenmann B (1994) Endosonography of neuroendocrine tumors of the stomach, duodenum, and pancreas. Ann N Y Acad Sci 733:425–436
Binstock AJ, Johnson CD, Stephens DH, Lloyd RV, Fletcher JG (2001) Carcinoid tumors of the stomach: a clinical and radiographic study. Am J Roentgenol 176:947–951
Dolcetta-Capuzzo A, Villa V, Albarello L, Franchi GM, Gemma M, Scavini M, Di Palo S, Orsenigo E, Bosi E, Doglioni C, Manzoni MF (2013) Gastroenteric neuroendocrine neoplasms classification: comparison of prognostic models. Cancer. 119:36–44
Gu P, Wu J, Newman E, Muggia F (2012) Treatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic origin. Int J Hepatol 2012:131659
Author information
Authors and Affiliations
Contributions
Pediredla Karunakar, Sriram Krishnamurthy, Aakash Chandran Chidambaram, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Sambandan Kumaravel, and Biswajit Dubashi managed the patient, reviewed the literature, and drafted the manuscript. Sriram Krishnamurthy critically revised the manuscript. Bheemanathi Hanuman Srinivas interpreted the histopathological findings. All authors contributed to the review of literature and drafting of the manuscript, and approved the final version of the manuscript. Sriram Krishnamurthy shall act as a guarantor of the paper.
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This refers to the article that can be found at https://doi.org/10.1007/s00467-020-04508-4.
Rights and permissions
About this article
Cite this article
Karunakar, P., Krishnamurthy, S., Chidambaram, A.C. et al. A rare case of severe hypertension with hypokalemic metabolic alkalosis in a 14-year-old girl: Answers. Pediatr Nephrol 35, 1633–1638 (2020). https://doi.org/10.1007/s00467-020-04509-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-020-04509-3